Shandong Homey Aquatic Development's controlling shareholder Tang Chuanqin has completed the acquisition of a total of 5 million shares.

16:43 26/12/2024

Good Home (600467.SH) announced that the company's chairman and actual controller, Tang Chuanqin, has completed the implementation of the increase plan.

Shandong Homey Aquatic Development (600467.SH) announcement: The company's chairman and actual controller, Tang Chuanqin's shareholding plan has been completed. Through centralized bidding transactions, a total of 5 million shares of the company's stock were acquired, accounting for 0.34% of the total share capital. The total amount of the acquisition is 7.1047 million yuan (excluding transaction costs).

C-MER MEDICAL (03309) spent 439,600 Hong Kong dollars to repurchase 230,000 shares on October 23rd.

TIANJIN DEV(00882): Tianjin Lisheng Pharmaceutical's net profit attributable to the parent company for the first three quarters was 371 million yuan, an increase of 119.05% year-on-year.

JACOBIO-B(01167) presented preclinical data on the Pan-KRAS inhibitor JAB-23E73 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

C-MER MEDICAL (03309) spent 439,600 Hong Kong dollars to repurchase 230,000 shares on October 23rd.

TIANJIN DEV(00882): Tianjin Lisheng Pharmaceutical's net profit attributable to the parent company for the first three quarters was 371 million yuan, an increase of 119.05% year-on-year.

JACOBIO-B(01167) presented preclinical data on the Pan-KRAS inhibitor JAB-23E73 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.